Impact of food preservatives based on immobilized phenolic compounds on an in vitro model of human gut microbiota.
Bacteroidetes
Covalent immobilization
Eugenol
Food preservatives
Gut microbiota
Natural antimicrobial
Journal
Food chemistry
ISSN: 1873-7072
Titre abrégé: Food Chem
Pays: England
ID NLM: 7702639
Informations de publication
Date de publication:
01 Mar 2023
01 Mar 2023
Historique:
received:
13
01
2022
revised:
13
09
2022
accepted:
18
09
2022
pubmed:
29
9
2022
medline:
11
11
2022
entrez:
28
9
2022
Statut:
ppublish
Résumé
To address concerns about the biocompatibility of novel phenolic immobilization-based food preservatives, their impact on the composition and metabonomic profile of a defined community of human gut microbiota was evaluated. Three phenolics (eugenol, vanillin and ferulic acid) presented in two forms (free or immobilized on different supports) were tested at two concentration levels (0.5 and 2 mg/mL). Free eugenol was the phenolic with the greatest impact on gut microbiota, with a remarkable increase in the abundance of Lachnospiraceae and Akkermansiaceae families. In contrast, immobilized phenolics produced an increase in the abundance of Bacteroides with a reduction in the ratio of Firmicutes to Bacteroidetes. The metabonomic profile was also affected by free and immobilized phenolics differently in terms of fermentation by-products and phenolic biotransformation metabolites. Thus the results suggest the importance of evaluating the impact of new compounds or materials added to food on human gut microbiota and their potential use to modulate microbiota composition.
Identifiants
pubmed: 36170787
pii: S0308-8146(22)02325-1
doi: 10.1016/j.foodchem.2022.134363
pii:
doi:
Substances chimiques
Food Preservatives
0
Eugenol
3T8H1794QW
Phenols
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
134363Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The author declare the following financial interests/personal relationships which may be considered as potential competing interests: Emma Allen-Vercoe is the CSO and co-founder of NuBiyota LLC, a company that is developing human gut microbiota-based live microbial products to treat a range of indications. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.